A urodynamic study on the effects of levodopa-carbidopa intestinal gel on urinary symptoms in Parkinson's disease

被引：0
|
作者：
Rinaldi, D. [1 ]
Voglino, O. [2 ]
Mattioli, M. [3 ]
Tubaro, A. [2 ]
Pontieri, F. [1 ]
机构：
[1] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs NESMOS, Rome, Italy
[2] Univ Roma La Sapienza, Dept Urol, Osped St Andrea, Rome, Italy
[3] NCL Neurol Ctr Latinum, Ist Neurosci, Rome, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-122
引用
收藏
页码：454 / 454
页数：1
相关论文
共 50 条
  • [21] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
    Francesc Valldeoriola
    María José Catalán
    Francisco Escamilla-Sevilla
    Eric Freire
    Jesús Olivares
    Esther Cubo
    Diego Santos García
    Matilde Calopa
    Pablo Martínez-Martín
    Juan Carlos Parra
    Gloria Arroyo
    José Matías Arbelo
    npj Parkinson's Disease, 7
  • [22] Weight, BMI, and Dyskinesia in Patients With Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel
    Pontieri, F.
    Bourgeois, P.
    Chaudhuri, K.
    Siddiqui, M.
    Bergmann, L.
    Kukreja, P.
    Ladhani, O.
    Simu, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 230 - 230
  • [23] Levodopa-Carbidopa Intestinal Gel Improves Long-term Parkinson's Disease Symptoms: Final Analysis of the DUOGLOBE Study
    Chaudhuri, K.
    Kovacs, N.
    Pontieri, F.
    Aldred, J.
    Bourgeois, P.
    Davis, T.
    Cubo, E.
    Anca-Herschkovitsch, M.
    Iansek, R.
    Siddiqui, M.
    Simu, M.
    Bergmann, L.
    Kukreja, P.
    Ladhani, O.
    Jia, J.
    Standaert, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 449 - 450
  • [24] Efficacy of Levodopa-Carbidopa Intestinal Gel Versus Oral Levodopa-Carbidopa in Advanced Parkinson's: Sensitivity and Responder Analyses
    Boyd, James T.
    Fernandez, Hubert H.
    Slevin, John T.
    Espay, Alberto J.
    Standaert, David G.
    Pritchett, Yili
    Zhang, Wuyan
    Chatamra, Krai
    Widnell, Katherine L.
    Benesh, Janet
    ANNALS OF NEUROLOGY, 2013, 74 : S44 - S44
  • [25] Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations
    R. Balestrino
    T. Martone
    M. Toffoli
    E. Montanaro
    M. Fabbri
    C. A. Artusi
    A. Romagnolo
    M. Zibetti
    M. Rizzone
    S. Goldwurm
    L. Lopiano
    A. H. V. Schapira
    Neurological Sciences, 2024, 45 : 1489 - 1497
  • [26] The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
    K. Ray Chaudhuri
    A. Simon Pickard
    Ali Alobaidi
    Yash J. Jalundhwala
    Prasanna L. Kandukuri
    Yanjun Bao
    Julia Sus
    Glynn Jones
    Christian Ridley
    Julia Oddsdottir
    Seyavash Najle-Rahim
    Matthew Madin-Warburton
    Weiwei Xu
    Anette Schrag
    PharmacoEconomics, 2022, 40 : 559 - 574
  • [27] Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations
    Balestrino, R.
    Martone, T.
    Toffoli, M.
    Montanaro, E.
    Fabbri, M.
    Artusi, C. A.
    Romagnolo, A.
    Zibetti, M.
    Rizzone, M.
    Goldwurm, S.
    Lopiano, L.
    Schapira, A. H. V.
    NEUROLOGICAL SCIENCES, 2024, 45 (04) : 1489 - 1497
  • [28] Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson's disease patients
    Karadag, Yesim Sucullu
    Saltoglu, Tugce
    Kucukdagli, Fadime Erdogan
    Ozturk, Omer
    Koseoglu, Tankut
    Altiparmak, Emin
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (01) : 84 - 89
  • [29] Does levodopa-carbidopa intestinal gel in Parkinson's disease patients increase the risk on polyneuropathy?
    Moes, H.
    Drent, M.
    Laar, T.
    MOVEMENT DISORDERS, 2017, 32
  • [30] Levodopa-carbidopa intestinal gel is an option in Parkinson’s disease with hyponatremia induced by dopamine agonists
    Marina Picillo
    Vincenzo Canoro
    Giulio Cicarelli
    Roberto Erro
    Paolo Barone
    Neurological Sciences, 2020, 41 : 3361 - 3363
12345